首页 > 最新文献

Cirugia Cardiovascular最新文献

英文 中文
C07. RENTABILIDAD DIAGNÓSTICA DE LA SEROLOGÍA PARA LEGIONELLA, MYCOPLASMA Y CHLAMYDIA EN LA ENDOCARDITIS INFECCIOSA, ¿ES HORA DE DECIR ADIÓS? C07。血清学对军团菌、支原体和衣原体在感染性内源性心脏病中的诊断效益,是时候决定ADIONS了吗?
IF 0.3 Q4 SURGERY Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.01.007
A. Estévez Prieto, R. Alonso, M. Machado, A. Álvarez-Uría, M. Valerio, E. Bouza, P. Muñoz
{"title":"C07. RENTABILIDAD DIAGNÓSTICA DE LA SEROLOGÍA PARA LEGIONELLA, MYCOPLASMA Y CHLAMYDIA EN LA ENDOCARDITIS INFECCIOSA, ¿ES HORA DE DECIR ADIÓS?","authors":"A. Estévez Prieto, R. Alonso, M. Machado, A. Álvarez-Uría, M. Valerio, E. Bouza, P. Muñoz","doi":"10.1016/j.circv.2025.01.007","DOIUrl":"10.1016/j.circv.2025.01.007","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 3","pages":"Page 177"},"PeriodicalIF":0.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144098927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estudio de cumplimiento terapéutico y aceptación de cambios en hábitos saludables en pacientes intervenidos de revascularización coronaria 研究接受冠状动脉血运重建手术患者的治疗依从性和对改变健康生活习惯的接受程度。
IF 0.3 Q4 SURGERY Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2023.10.002
Delfina Fletcher-Sanfeliu, Laura Vidal, Fernando Enríquez, Rubén Tarrío, Daniel Padrol, Irene Hidalgo, Alcides José Velásquez, Marina Rigo, Ramon Lluis Barril, José Ignacio Sáez de Ibarra

Introducción

La enfermedad cardiovascular es la principal causa de morbimortalidad a nivel mundial y su prevención es coste-eficaz. El objetivo del estudio es conocer el estado de los factores de riesgo cardiovascular modificables en los pacientes coronarios sometidos a cirugía coronaria para averiguar los puntos dónde se debe hacer mayor incisión para la mejora de la prevención secundaria y tratamiento de la cardiopatía isquémica.

Material y métodos

Estudio sobre cumplimiento terapéutico y aceptación de cambios en los hábitos de vida saludables en pacientes intervenidos de cirugía coronaria. Se diseñó una encuesta telefónica dirigida a los pacientes coronarios intervenidos en 2019 a los 12 meses de la intervención, para conocer el estado de los factores de riesgo cardiovascular antes de la intervención, los consejos recibidos y la actual situación de los mismos.

Resultados

133 pacientes fueron incluidos en el estudio. Hubo una reducción del 59% en el consumo de tabaco, un aumento del 15% en la actividad física, del 86% en el consumo de dieta saludable y del 48% en el control adecuado de la diabetes. La mayoría lograron mejorar el control de la tensión arterial y las cifras lipídicas y el seguimiento por cardiología. No hubo modificación del peso en aquellos pacientes con sobrepeso u obesidad.

Conclusiones

Se observó una adecuada adherencia a los cambios en los hábitos de vida saludables modificables tras una intervención coronaria, pero persiste necesidad de mejora en el cese del hábito tabáquico, el aumento de la actividad física y en la reducción del peso corporal.

Introduction

Cardiovascular disease is a leading cause of morbidity and mortality worldwide and its prevention is cost-efficient. The objective of the study is to determine the modifiable cardiovascular risk factors in coronary patients after coronary surgery in order to detect the key points to improve the secondary prevention in ischemic heart disease.

Methods

Study about therapeutic compliance and acceptance of healthy lifestyle habits changes in patients who have undergone coronary artery bypass surgery. A telephone survey was designed for coronary surgery patients who underwent surgery in 2019 at 12 months of follow-up in order to know the past and present status of cardiovascular risk factors.

Results

The study included 133 patients. It was observed a reduction of tobacco smoking of 59%, a 15% increase in physical activity, a 86% increase in healthy diet intake and a 48% improvement in diabetes control. The whole majority achieved an adequate control of hypertension and lipid levels. There was no weightloss in those patients with overweight or obesity.

Conclusions

The compliance of lifestyle changes for modifiable risk factors after coronary surgery is appropr
心血管疾病是全球发病和死亡的主要原因,其预防具有成本效益。本研究的目的是了解接受冠状动脉手术的冠状动脉患者可改变的心血管危险因素的状况,以确定在哪些地方需要进行更大的切口,以改善缺血性心脏病的二级预防和治疗。材料和方法冠状动脉手术患者治疗依从性和对健康生活习惯变化的接受程度的研究。我们设计了一项电话调查,对象是2019年进行手术12个月后的冠状动脉患者,以了解手术前心血管危险因素的状态、建议和当前状态。结果包括133例患者。烟草使用减少了59%,体育活动增加了15%,健康饮食减少了86%,适当控制糖尿病减少了48%。大多数成功地改善了血压和血脂控制以及心脏病学监测。超重或肥胖患者的体重没有变化。结论:在冠状动脉干预后,观察到对可改变的健康生活方式的改变有充分的依从性,但在戒烟、增加体育活动和减轻体重方面仍有改进的需要。导管心血管疾病是全球发病率和死亡率的主要原因,其预防具有成本效益。本研究的目的是确定冠状动脉手术后冠状动脉患者可改变的心血管危险因素,以确定改善缺血性心脏病二级预防的关键点。冠状动脉搭桥手术患者治疗依从性和接受健康生活习惯改变的方法研究。一项电话调查是为2019年在12个月的随访中接受手术的冠状动脉外科患者设计的,以了解心血管危险因素的过去和现在的状态。结果这项研究包括133名患者。研究发现,吸烟减少了59%,体育活动增加了15%,健康饮食摄入量增加了86%,糖尿病控制改善了48%。大多数患者的高血压和脂质水平得到了充分的控制。在那些超重或肥胖的患者中没有体重减轻。结论:冠状动脉手术后生活方式的改变是否符合可改变的风险因素是适当的。这是一个很好的机会,让你的生活更美好,你的生活更美好。
{"title":"Estudio de cumplimiento terapéutico y aceptación de cambios en hábitos saludables en pacientes intervenidos de revascularización coronaria","authors":"Delfina Fletcher-Sanfeliu,&nbsp;Laura Vidal,&nbsp;Fernando Enríquez,&nbsp;Rubén Tarrío,&nbsp;Daniel Padrol,&nbsp;Irene Hidalgo,&nbsp;Alcides José Velásquez,&nbsp;Marina Rigo,&nbsp;Ramon Lluis Barril,&nbsp;José Ignacio Sáez de Ibarra","doi":"10.1016/j.circv.2023.10.002","DOIUrl":"10.1016/j.circv.2023.10.002","url":null,"abstract":"<div><h3>Introducción</h3><div>La enfermedad cardiovascular es la principal causa de morbimortalidad a nivel mundial y su prevención es coste-eficaz. El objetivo del estudio es conocer el estado de los factores de riesgo cardiovascular modificables en los pacientes coronarios sometidos a cirugía coronaria para averiguar los puntos dónde se debe hacer mayor incisión para la mejora de la prevención secundaria y tratamiento de la cardiopatía isquémica.</div></div><div><h3>Material y métodos</h3><div>Estudio sobre cumplimiento terapéutico y aceptación de cambios en los hábitos de vida saludables en pacientes intervenidos de cirugía coronaria. Se diseñó una encuesta telefónica dirigida a los pacientes coronarios intervenidos en 2019 a los 12 meses de la intervención, para conocer el estado de los factores de riesgo cardiovascular antes de la intervención, los consejos recibidos y la actual situación de los mismos.</div></div><div><h3>Resultados</h3><div>133 pacientes fueron incluidos en el estudio. Hubo una reducción del 59% en el consumo de tabaco, un aumento del 15% en la actividad física, del 86% en el consumo de dieta saludable y del 48% en el control adecuado de la diabetes. La mayoría lograron mejorar el control de la tensión arterial y las cifras lipídicas y el seguimiento por cardiología. No hubo modificación del peso en aquellos pacientes con sobrepeso u obesidad.</div></div><div><h3>Conclusiones</h3><div>Se observó una adecuada adherencia a los cambios en los hábitos de vida saludables modificables tras una intervención coronaria, pero persiste necesidad de mejora en el cese del hábito tabáquico, el aumento de la actividad física y en la reducción del peso corporal.</div></div><div><h3>Introduction</h3><div>Cardiovascular disease is a leading cause of morbidity and mortality worldwide and its prevention is cost-efficient. The objective of the study is to determine the modifiable cardiovascular risk factors in coronary patients after coronary surgery in order to detect the key points to improve the secondary prevention in ischemic heart disease.</div></div><div><h3>Methods</h3><div>Study about therapeutic compliance and acceptance of healthy lifestyle habits changes in patients who have undergone coronary artery bypass surgery. A telephone survey was designed for coronary surgery patients who underwent surgery in 2019 at 12 months of follow-up in order to know the past and present status of cardiovascular risk factors.</div></div><div><h3>Results</h3><div>The study included 133 patients. It was observed a reduction of tobacco smoking of 59%, a 15% increase in physical activity, a 86% increase in healthy diet intake and a 48% improvement in diabetes control. The whole majority achieved an adequate control of hypertension and lipid levels. There was no weightloss in those patients with overweight or obesity.</div></div><div><h3>Conclusions</h3><div>The compliance of lifestyle changes for modifiable risk factors after coronary surgery is appropr","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 3","pages":"Pages 132-138"},"PeriodicalIF":0.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140465641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dr. José Luis vallejo Ruíz Jose Luis Vallejo Ruiz博士
IF 0.3 Q4 SURGERY Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.03.008
José María González Santos
{"title":"Dr. José Luis vallejo Ruíz","authors":"José María González Santos","doi":"10.1016/j.circv.2025.03.008","DOIUrl":"10.1016/j.circv.2025.03.008","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 3","pages":"Page 174"},"PeriodicalIF":0.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144098836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cirugía cardiovascular en España en el año 2023. Registro de intervenciones de la Sociedad Española de Cirugía Cardiovascular y Endovascular 2018年在中国进行心脏手术。西班牙心血管和血管内外科学会的手术登记
IF 0.3 Q4 SURGERY Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.03.006
Emilio Monguió Santín , Elio Martín Gutiérrez , Gregorio Cuerpo Caballero , Tomasa Centella Hernández , Luz Polo López , Rafael García Fuster , Encarnación Gutiérrez Carretero , Pilar Gascón García-Verdugo , Juan José Legarra Calderón
This registry provides the data corresponding to cardiovascular surgery activity performed in Spain during 2023. This registry is anonymous and voluntary, and it is compiled from aggregated data from hospitals across the country, which transfer their data to the Spanish Society of Cardiovascular and Endovascular Surgery (SECCE). It is the thirty-fifth consecutive registry of cardiovascular surgical activity in our country. This registry allows for an assessment of the situation of the specialty in Spain, as well as the impact of the recent pandemic, the introduction of new interventional techniques, and the implementation of new clinical practice guidelines. The SECCE intervention registry also serves as a source of information to compare current and future procedural outcomes.
In 2023, 59 centers in Spain reported their activity, compared to 58 the previous year. A total of 32,497 interventions were performed. Of these, 21,374 were major cardiac surgeries, of which 18,940 involved the use of extracorporeal circulation. Acquired heart disease accounted for 18,708 interventions, while 1,989 were for congenital heart disease. Additionally, 3,132 peripheral vascular surgery procedures were carried out.
Regarding the type of pathology treated, 7,990 isolated valve interventions were performed, 1,651 combined valve and coronary surgeries, 4,910 isolated coronary revascularization procedures (30.16% without the use of extracorporeal circulation), 2,624 aortic surgeries, and 516 transcatheter valve prosthesis implants.
Compared to 2022, there is an increase in overall surgical activity, although data from an additional center were obtained. Therefore, the image provided by this registry is a Fairly accurate reflection of cardiovascular surgery activity in Spain. The proportion of interventions for major pathology groups remains stable compared to previous years, with isolated valve surgery once again being the most common group. In general, the observed mortality was below the mortality predicted by risk scales in most areas of the specialty.
该注册表提供了2023年西班牙心血管手术活动的相应数据。该登记是匿名和自愿的,它是根据来自全国各地医院的汇总数据编制的,这些医院将其数据转移到西班牙心血管和血管内外科学会(SECCE)。这是我国连续第35次心血管手术活动登记。通过这一登记,可以评估西班牙该专业的情况,以及最近大流行病的影响、新介入技术的采用和新的临床实践准则的实施情况。SECCE干预登记也可作为比较当前和未来程序结果的信息来源。2023年,西班牙有59个中心报告了它们的活动,而前一年为58个。总共进行了32,497次干预。其中,21,374例为大型心脏手术,其中18,940例涉及体外循环。获得性心脏病占18,708例干预,而先天性心脏病占1,989例。此外,进行了3132例周围血管手术。就治疗的病理类型而言,进行了7,990例孤立瓣膜介入手术,1,651例瓣膜与冠状动脉联合手术,4,910例孤立冠状动脉重建术(30.16%不使用体外循环),2,624例主动脉手术,516例经导管瓣膜假体植入。与2022年相比,总体手术活动有所增加,尽管数据来自另一个中心。因此,该登记处提供的图像相当准确地反映了西班牙的心血管手术活动。与前几年相比,主要病理组的干预比例保持稳定,孤立性瓣膜手术再次成为最常见的组。一般来说,观察到的死亡率低于死亡率预测的风险量表在大多数领域的专业。
{"title":"Cirugía cardiovascular en España en el año 2023. Registro de intervenciones de la Sociedad Española de Cirugía Cardiovascular y Endovascular","authors":"Emilio Monguió Santín ,&nbsp;Elio Martín Gutiérrez ,&nbsp;Gregorio Cuerpo Caballero ,&nbsp;Tomasa Centella Hernández ,&nbsp;Luz Polo López ,&nbsp;Rafael García Fuster ,&nbsp;Encarnación Gutiérrez Carretero ,&nbsp;Pilar Gascón García-Verdugo ,&nbsp;Juan José Legarra Calderón","doi":"10.1016/j.circv.2025.03.006","DOIUrl":"10.1016/j.circv.2025.03.006","url":null,"abstract":"<div><div>This registry provides the data corresponding to cardiovascular surgery activity performed in Spain during 2023. This registry is anonymous and voluntary, and it is compiled from aggregated data from hospitals across the country, which transfer their data to the Spanish Society of Cardiovascular and Endovascular Surgery (SECCE). It is the thirty-fifth consecutive registry of cardiovascular surgical activity in our country. This registry allows for an assessment of the situation of the specialty in Spain, as well as the impact of the recent pandemic, the introduction of new interventional techniques, and the implementation of new clinical practice guidelines. The SECCE intervention registry also serves as a source of information to compare current and future procedural outcomes.</div><div>In 2023, 59 centers in Spain reported their activity, compared to 58 the previous year. A total of 32,497 interventions were performed. Of these, 21,374 were major cardiac surgeries, of which 18,940 involved the use of extracorporeal circulation. Acquired heart disease accounted for 18,708 interventions, while 1,989 were for congenital heart disease. Additionally, 3,132 peripheral vascular surgery procedures were carried out.</div><div>Regarding the type of pathology treated, 7,990 isolated valve interventions were performed, 1,651 combined valve and coronary surgeries, 4,910 isolated coronary revascularization procedures (30.16% without the use of extracorporeal circulation), 2,624 aortic surgeries, and 516 transcatheter valve prosthesis implants.</div><div>Compared to 2022, there is an increase in overall surgical activity, although data from an additional center were obtained. Therefore, the image provided by this registry is a Fairly accurate reflection of cardiovascular surgery activity in Spain. The proportion of interventions for major pathology groups remains stable compared to previous years, with isolated valve surgery once again being the most common group. In general, the observed mortality was below the mortality predicted by risk scales in most areas of the specialty.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 3","pages":"Pages 151-165"},"PeriodicalIF":0.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144098838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Herniación cardiaca secundaria a traumatismo torácico penetrante 继发性心脏损伤至胸腔穿透性外伤
IF 0.3 Q4 SURGERY Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2024.08.003
María Paula Forero-Ríos , Néstor Sandoval , Gabriela Fuentes Navarrete , María Camila de Vivero , Diego Fernando Salcedo Miranda , Mauricio Pedraza Ciro
{"title":"Herniación cardiaca secundaria a traumatismo torácico penetrante","authors":"María Paula Forero-Ríos ,&nbsp;Néstor Sandoval ,&nbsp;Gabriela Fuentes Navarrete ,&nbsp;María Camila de Vivero ,&nbsp;Diego Fernando Salcedo Miranda ,&nbsp;Mauricio Pedraza Ciro","doi":"10.1016/j.circv.2024.08.003","DOIUrl":"10.1016/j.circv.2024.08.003","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 3","pages":"Pages 168-170"},"PeriodicalIF":0.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144098840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C02. INFECCIONES ASOCIADAS A DISPOSITIVOS CARDIACOS IMPLANTABLES EN UN HOSPITAL DE TERCER NIVEL: EXPERIENCIA DE 5 AÑOS 、。三级医院与心脏植入物相关的感染:5年经验
IF 0.3 Q4 SURGERY Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.01.015
I. Aramburu Fuentenebro, M.A. Cañas, J. García-González, G. Cuervo, M. Hernández-Meneses, A. Perissinotti, B. Vidal, E. Quintana, J. Llopis, A. Moreno, J.M. Miró, Grupo de estudio de la endocarditis del Hospital Clínic
{"title":"C02. INFECCIONES ASOCIADAS A DISPOSITIVOS CARDIACOS IMPLANTABLES EN UN HOSPITAL DE TERCER NIVEL: EXPERIENCIA DE 5 AÑOS","authors":"I. Aramburu Fuentenebro,&nbsp;M.A. Cañas,&nbsp;J. García-González,&nbsp;G. Cuervo,&nbsp;M. Hernández-Meneses,&nbsp;A. Perissinotti,&nbsp;B. Vidal,&nbsp;E. Quintana,&nbsp;J. Llopis,&nbsp;A. Moreno,&nbsp;J.M. Miró,&nbsp;Grupo de estudio de la endocarditis del Hospital Clínic","doi":"10.1016/j.circv.2025.01.015","DOIUrl":"10.1016/j.circv.2025.01.015","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 3","pages":"Page 181"},"PeriodicalIF":0.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144098841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C04. TRATAMIENTO ANTIBIÓTICO SUPRESIVO Y SUPERVIVENCIA A 5 AÑOS EN ENDOCARDITIS DE DISPOSITIVO CARDIACO NO RETIRADO C04。对5岁内源性心脏病患者进行强化抗微生物药物治疗和随访治疗
IF 0.3 Q4 SURGERY Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.01.005
M. Hernández-Meneses, E. Sandoval, G. Cuervo, C. Falces, A. Perissinotti, F. Marco, J.M. Tolosana, J. Llopis, A. Moreno, J.M. Miró
{"title":"C04. TRATAMIENTO ANTIBIÓTICO SUPRESIVO Y SUPERVIVENCIA A 5 AÑOS EN ENDOCARDITIS DE DISPOSITIVO CARDIACO NO RETIRADO","authors":"M. Hernández-Meneses,&nbsp;E. Sandoval,&nbsp;G. Cuervo,&nbsp;C. Falces,&nbsp;A. Perissinotti,&nbsp;F. Marco,&nbsp;J.M. Tolosana,&nbsp;J. Llopis,&nbsp;A. Moreno,&nbsp;J.M. Miró","doi":"10.1016/j.circv.2025.01.005","DOIUrl":"10.1016/j.circv.2025.01.005","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 3","pages":"Page 176"},"PeriodicalIF":0.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144098904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C05. INFECCIÓN CRÓNICA EN ASISTENCIA VENTRICULAR POR ENTEROCOCCUS FAECALIS: TRATAMIENTO ANTIBIÓTICO INDEFINIDO C05。假肠球菌引起的慢性腹腔辅助感染:不明确的抗结核治疗
IF 0.3 Q4 SURGERY Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.01.006
C. Gay , A. Perissinotti , E. Sandoval , M. Farrero , S.M. San José , B. Vidal , D. Fuster , G. Cuervo , J.M. Miró , M. Hernández-Meneses
{"title":"C05. INFECCIÓN CRÓNICA EN ASISTENCIA VENTRICULAR POR ENTEROCOCCUS FAECALIS: TRATAMIENTO ANTIBIÓTICO INDEFINIDO","authors":"C. Gay ,&nbsp;A. Perissinotti ,&nbsp;E. Sandoval ,&nbsp;M. Farrero ,&nbsp;S.M. San José ,&nbsp;B. Vidal ,&nbsp;D. Fuster ,&nbsp;G. Cuervo ,&nbsp;J.M. Miró ,&nbsp;M. Hernández-Meneses","doi":"10.1016/j.circv.2025.01.006","DOIUrl":"10.1016/j.circv.2025.01.006","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 3","pages":"Pages 176-177"},"PeriodicalIF":0.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144098905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C14. CARACTERIZACIÓN DE LOS SUPERVIVIENTES AL INGRESO HOSPITALARIO POR ENDOCARDITIS INFECCIOSA IZQUIERDA DESESTIMADOS PARA CIRUGÍA CARDIACA C14。为心脏手术预留的左旋传染性内源性心脏病患者住院收入的特征
IF 0.3 Q4 SURGERY Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.01.008
M. Miguez, P. Vilardell, S. Moral, D. Bosch, X. Salgado, P. Álvarez, N. Cañete, N. Ferran, R. Brugada
{"title":"C14. CARACTERIZACIÓN DE LOS SUPERVIVIENTES AL INGRESO HOSPITALARIO POR ENDOCARDITIS INFECCIOSA IZQUIERDA DESESTIMADOS PARA CIRUGÍA CARDIACA","authors":"M. Miguez,&nbsp;P. Vilardell,&nbsp;S. Moral,&nbsp;D. Bosch,&nbsp;X. Salgado,&nbsp;P. Álvarez,&nbsp;N. Cañete,&nbsp;N. Ferran,&nbsp;R. Brugada","doi":"10.1016/j.circv.2025.01.008","DOIUrl":"10.1016/j.circv.2025.01.008","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 3","pages":"Page 177"},"PeriodicalIF":0.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144098928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C11. TERAPIA ANTIBIÓTICA DOMICILIARIA ENDOVENOSA (TADE) EN EL TRATAMIENTO DE INFECCIONES ENDOVASCULARES C11。治疗血管内感染的多聚体抗结核疗法(TADE)
IF 0.3 Q4 SURGERY Pub Date : 2025-05-01 DOI: 10.1016/j.circv.2025.01.020
A. Licetti Bermúdez, P. García González, S. Santos Seoane, R. Pampín Sánchez, S. Tembrás Martínez, I.C. Bayón Cubero, A. Rodríguez-Guardado
{"title":"C11. TERAPIA ANTIBIÓTICA DOMICILIARIA ENDOVENOSA (TADE) EN EL TRATAMIENTO DE INFECCIONES ENDOVASCULARES","authors":"A. Licetti Bermúdez,&nbsp;P. García González,&nbsp;S. Santos Seoane,&nbsp;R. Pampín Sánchez,&nbsp;S. Tembrás Martínez,&nbsp;I.C. Bayón Cubero,&nbsp;A. Rodríguez-Guardado","doi":"10.1016/j.circv.2025.01.020","DOIUrl":"10.1016/j.circv.2025.01.020","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 3","pages":"Page 184"},"PeriodicalIF":0.3,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144098653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cirugia Cardiovascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1